Success Metrics

Clinical Success Rate
96.7%

Based on 59 completed trials

Completion Rate
97%(59/61)
Active Trials
15(18%)
Results Posted
34%(20 trials)
Terminated
2(2%)

Phase Distribution

Ph not_applicable
28
34%
Ph early_phase_1
8
10%
Ph phase_3
4
5%
Ph phase_2
8
10%
Ph phase_1
26
32%
Ph phase_4
4
5%

Phase Distribution

34

Early Stage

8

Mid Stage

8

Late Stage

Phase Distribution78 total trials
Early Phase 1First-in-human
8(10.3%)
Phase 1Safety & dosage
26(33.3%)
Phase 2Efficacy & side effects
8(10.3%)
Phase 3Large-scale testing
4(5.1%)
Phase 4Post-market surveillance
4(5.1%)
N/ANon-phased studies
28(35.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.7%

59 of 63 finished

Non-Completion Rate

6.3%

4 ended early

Currently Active

15

trials recruiting

Total Trials

82

all time

Status Distribution
Active(15)
Completed(59)
Terminated(4)
Other(4)

Detailed Status

Completed59
Recruiting13
unknown4
Withdrawn2
Active, not recruiting2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
82
Active
15
Success Rate
96.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 18 (10.3%)
Phase 126 (33.3%)
Phase 28 (10.3%)
Phase 34 (5.1%)
Phase 44 (5.1%)
N/A28 (35.9%)

Trials by Status

unknown45%
withdrawn22%
completed5972%
active_not_recruiting22%
terminated22%
recruiting1316%

Recent Activity

Clinical Trials (82)

Showing 20 of 82 trialsScroll for more
NCT03575403Phase 1

Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)

Completed
NCT03955510Not Applicable

Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis

Active Not Recruiting
NCT00713492Phase 1

Computer-Assisted Self-Administration of Ethanol

Completed
NCT06326684Early Phase 1

Suvorexant and Alcohol

Recruiting
NCT05929677Early Phase 1

Impulsivity Domains and Subjective Response

Recruiting
NCT04929288Not Applicable

Neural and Hormonal Influences on Sex Differences in Risk for AUD

Recruiting
NCT06293638

Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor

Recruiting
NCT06002633Not Applicable

Approach-Avoidance and Alcohol Challenge Study in PTSD

Recruiting
NCT07282405Not Applicable

Validation of Alcohol Level Identification Using DRIVESC

Completed
NCT06264791Not Applicable

Stress-motivated Alcohol Use as a Value-based Decision-making Process

Completed
NCT06579521Not Applicable

Real-world Experiences of Alcohol and Cognitions Over Time

Completed
NCT06576674Not Applicable

Satiety and Alcohol Challenge

Completed
NCT04300751Phase 1

The Behavioral Effects of Opioids and Alcohol

Completed
NCT06259916Not Applicable

Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)

Recruiting
NCT04931095Phase 1

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

Completed
NCT06293040Phase 1

Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment

Recruiting
NCT05973656Not Applicable

Role of Acetaldehyde in the Development of Oral Cancer

Recruiting
NCT04595682Not Applicable

Estradiol Effects on Alcohol Across the Menstrual Cycle

Completed
NCT05692830

Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms

Recruiting
NCT00295334Phase 2

Moderate Alcohol Intake Among Patients With Type 2 Diabetes

Completed

Drug Details

Intervention Type
DRUG
Total Trials
82